FORM 8-K

Company

Eton Pharmaceuticals, Inc.

Filed

March 2, 2026

Period of Report

February 27, 2026

Accession Number

0001437749-26-006209

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →